Article ; Online: Where are we with the benefit-risk ratio of JAK inhibitors in rheumatoid arthritis?
2022 Volume 89, Issue 6, Page(s) 105454
MeSH term(s) | Humans ; Janus Kinase Inhibitors/therapeutic use ; Odds Ratio ; Arthritis, Rheumatoid/drug therapy ; Antirheumatic Agents/therapeutic use ; Antirheumatic Agents/pharmacology |
---|---|
Chemical Substances | Janus Kinase Inhibitors ; Antirheumatic Agents |
Language | English |
Publishing date | 2022-08-12 |
Publishing country | France |
Document type | Editorial |
ZDB-ID | 2020487-5 |
ISSN | 1778-7254 ; 1297-319X |
ISSN (online) | 1778-7254 |
ISSN | 1297-319X |
DOI | 10.1016/j.jbspin.2022.105454 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 4590: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.